The 100 largest Healthcare companies by market cap, with valuation and cash-flow metrics.
| Ticker | Company | Market cap | P/E | FCF yield |
|---|---|---|---|---|
| LLY | Eli Lilly and Company | $1.04T | 37.2 | 0.6% |
| JNJ | Johnson & Johnson | $648.72B | 24.8 | 3.0% |
| ABBV | AbbVie Inc. | $468.66B | 24.4 | 3.8% |
| MRK | Merck & Co., Inc. | $372.32B | 47.0 | 3.3% |
| UNH | UnitedHealth Group Incorporated | $334.76B | 20.0 | 4.7% |
| NVS | Novartis AG | $268.53B | 16.9 | 5.5% |
| AZN | AstraZeneca PLC | $261.12B | 36.7 | 3.3% |
| TMO | Thermo Fisher Scientific Inc. | $243.49B | 27.6 | 2.5% |
| AMGN | Amgen Inc. | $221.79B | 18.3 | 3.6% |
| GILD | Gilead Sciences, Inc. | $189.30B | — | 4.9% |
| ABT | Abbott Laboratories | $179.42B | 19.7 | 4.1% |
| NVO | Novo Nordisk A/S | $174.02B | 11.0 | 2.5% |
| PFE | Pfizer Inc. | $159.19B | 9.2 | 5.7% |
| DHR | Danaher Corporation | $155.42B | 27.2 | 3.3% |
| ISRG | Intuitive Surgical, Inc. | $144.06B | 39.3 | 1.7% |
| VRTX | Vertex Pharmaceuticals Incorporated | $130.53B | 27.1 | 2.4% |
| BMY | Bristol-Myers Squibb Company | $127.16B | 9.6 | 10.1% |
| MDT | Medtronic plc | $116.11B | 15.9 | 4.6% |
| CVS | CVS Health Corporation | $111.40B | 11.1 | 7.0% |
| SYK | Stryker Corporation | $105.52B | 19.7 | 4.0% |
| MCK | McKesson Corporation | $103.91B | 21.8 | 4.9% |
| SNY | Sanofi | $101.86B | 8.7 | 8.0% |
| GSK | GSK plc | $101.58B | 10.7 | 6.1% |
| HCA | HCA Healthcare, Inc. | $94.85B | 14.8 | 7.3% |
| ELV | Elevance Health, Inc. | $87.27B | 13.7 | 3.5% |
| REGN | Regeneron Pharmaceuticals, Inc. | $82.77B | 17.1 | 4.3% |
| MRNA | Moderna Inc | $72.88B | — | -2.9% |
| CI | The Cigna Group | $72.33B | 8.7 | 11.4% |
| BSX | Boston Scientific Corporation | $65.10B | 14.0 | 5.1% |
| TAK | Takeda Pharmaceutical Company Limited | $60.52B | 37.9 | 6.6% |
| COR | Cencora, Inc. | $60.00B | 18.3 | 5.2% |
| ARGX | argenx SE | $59.94B | 37.0 | 0.9% |
| NTRA | Natera, Inc. | $56.35B | — | 0.1% |
| CAH | Cardinal Health, Inc. | $51.42B | 20.3 | 8.6% |
| EW | Edwards Lifesciences Corporation | $51.17B | 31.6 | 2.6% |
| BDX | Becton, Dickinson and Company | $49.85B | 14.1 | 5.1% |
| A | Agilent Technologies, Inc. | $47.16B | 27.6 | 2.4% |
| MDLN | Medline Inc. | $46.32B | — | 4.7% |
| TEVA | Teva Pharmaceutical Industries Limited | $46.09B | 17.3 | 2.5% |
| HUM | Humana Inc. | $44.67B | 21.6 | 0.8% |
| IQV | IQVIA Holdings Inc. | $44.46B | 21.7 | 4.4% |
| VEEV | Veeva Systems Inc | $42.24B | 30.0 | 3.2% |
| WAT | Waters Corporation | $41.80B | 31.1 | 2.1% |
| ONC | BeOne Medicines AG | $41.64B | 64.8 | 2.1% |
| RVMD | Revolution Medicines, Inc. | $41.34B | — | -2.5% |
| IDXX | IDEXX Laboratories, Inc. | $41.08B | 36.7 | 2.5% |
| HLN | Haleon plc | $40.68B | 21.5 | 7.1% |
| ILMN | Illumina, Inc. | $37.37B | 48.0 | 2.4% |
| RPRX | Royalty Pharma plc | $33.81B | 11.1 | 7.5% |
| DXCM | DexCom, Inc. | $33.79B | 35.1 | 3.0% |
| ALNY | Alnylam Pharmaceuticals, Inc. | $33.67B | 31.5 | 1.4% |
| BIIB | Biogen Inc. | $33.30B | 16.1 | 5.9% |
| RMD | ResMed Inc. | $32.02B | 19.9 | 3.9% |
| ALC | Alcon Inc. | $31.71B | 20.1 | 4.9% |
| CNC | Centene Corporation | $31.27B | 12.2 | 13.8% |
| ZTS | Zoetis Inc. | $30.11B | 11.1 | 7.0% |
| GEHC | GE HealthCare Technologies Inc. | $29.93B | 14.3 | 5.0% |
| MTD | Mettler-Toledo International Inc. | $29.87B | 33.2 | 2.8% |
| ROIV | Roivant Sciences Ltd. | $27.61B | — | -2.9% |
| INSM | Insmed Incorporated | $26.38B | — | -4.0% |
| WST | West Pharmaceutical Services, Inc. | $26.12B | 43.7 | 1.7% |
| DGX | Quest Diagnostics Incorporated | $25.91B | 22.1 | 5.1% |
| INCY | Incyte Corporation | $25.73B | 14.2 | 5.2% |
| BNTX | BioNTech SE | $25.34B | — | -1.4% |
| LH | Labcorp Holdings Inc. | $25.27B | 17.8 | 4.6% |
| PHG | Koninklijke Philips N.V. | $24.41B | 12.8 | 2.4% |
| GH | Guardant Health, Inc. | $23.77B | — | -1.1% |
| GMAB | Genmab A/S | $21.66B | 23.8 | 5.1% |
| UTHR | United Therapeutics Corporation | $21.34B | 17.8 | 4.3% |
| THC | Tenet Healthcare Corporation | $21.10B | 13.6 | 10.6% |
| STE | STERIS plc | $20.36B | 20.0 | 4.7% |
| VTRS | Viatris Inc. | $19.73B | 6.8 | 9.2% |
| ZBH | Zimmer Biomet Holdings, Inc. | $17.93B | 11.1 | 7.6% |
| MEDP | Medpace Holdings, Inc. | $17.59B | 36.9 | 3.7% |
| RVTY | Revvity, Inc. | $15.99B | 26.8 | 3.0% |
| ASND | Ascendis Pharma A/S | $15.63B | — | 0.4% |
| JAZZ | Jazz Pharmaceuticals plc | $15.62B | 9.0 | 7.8% |
| SOLV | Solventum Corporation | $15.11B | 12.5 | -0.1% |
| NBIX | Neurocrine Biosciences, Inc. | $14.46B | 16.1 | 5.1% |
| EXEL | Exelixis, Inc. | $14.41B | 16.6 | 5.2% |
| TEM | Tempus AI, Inc. | $13.93B | — | -1.8% |
| CRL | Charles River Laboratories International, Inc. | $13.73B | 28.8 | 3.7% |
| SMMT | Summit Therapeutics Inc. | $13.66B | — | -2.5% |
| BBIO | BridgeBio Pharma, Inc. | $13.53B | — | -3.4% |
| HALO | Halozyme Therapeutics, Inc. | $13.07B | 21.5 | 2.5% |
| ICLR | ICON Public Limited Company | $12.89B | 14.4 | 6.5% |
| CORT | Corcept Therapeutics Incorporated | $12.70B | 279.8 | 1.0% |
| PEN | Penumbra, Inc. | $12.58B | 76.6 | 1.4% |
| BMRN | BioMarin Pharmaceutical Inc. | $12.27B | 24.9 | 5.7% |
| BAX | Baxter International Inc. | $12.24B | 11.6 | 2.7% |
| EHC | Encompass Health Corporation | $12.11B | 21.0 | 3.5% |
| MDGL | Madrigal Pharmaceuticals, Inc. | $11.99B | — | -1.7% |
| FMS | Fresenius Medical Care AG | $11.97B | 9.8 | 15.5% |
| DVA | DaVita Inc. | $11.72B | 14.3 | 9.4% |
| SNN | Smith & Nephew plc | $11.51B | 12.2 | 7.1% |
| ELAN | Elanco Animal Health Incorporated | $11.45B | 21.6 | 2.5% |
| TECH | Bio-Techne Corporation | $11.38B | 37.6 | 2.3% |
| BTSG | BrightSpring Health Services, Inc. | $11.19B | 38.5 | 3.2% |
| TWST | Twist Bioscience Corporation | $10.91B | — | -0.8% |
| ALGN | Align Technology, Inc. | $10.89B | 13.8 | 4.4% |